No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status

被引:145
作者
Rankinen, T
Wolfarth, B
Simoneau, JA
Maier-Lenz, D
Rauramaa, R
Rivera, MA
Boulay, MR
Chagnon, YC
Pérusse, L
Keul, J
Bouchard, C
机构
[1] Pennington Biomed Res Ctr, Human Genomics Lab, Baton Rouge, LA 70808 USA
[2] Univ Freiburg, Dept Prevent Rehabil & Sports Med, D-79106 Freiburg, Germany
[3] Univ Laval, Phys Act Sci Lab, Ste Foy, PQ G1K 7P4, Canada
[4] Univ Kuopio, Dept Physiol, Kuopio Res Inst Exercise Med, Kuopio 70100, Finland
[5] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, Kuopio 70100, Finland
[6] Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA
[7] Univ Puerto Rico, Sch Med, Dept Phys Med Rehabil & Sports Med, San Juan, PR 00936 USA
关键词
genetics; sports; endurance performance; insertion/deletion;
D O I
10.1152/jappl.2000.88.5.1571
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Several studies have reported that the insertion (I) allele of the angiotensin-converting enzyme (ACE) I/deletion (D) polymorphism is associated with enhanced responsiveness to endurance training and is more common in endurance athletes than in sedentary controls. We tested the latter hypothesis in a cohort of 192 male endurance athletes with maximal oxygen uptake greater than or equal to 75 ml kg-l min-l and 189 sedentary male controls. The ACE ID polymorphism in intron 16 was typed with the three-primer polymerase chain reaction method. Both the genotype (P = 0.214) and allele (P = 0.095) frequencies were similar in the athletes and the controls. Further analyses in the athletes revealed no excess of the I allele among the athletes within the highest quartile (> 80 mi kg(-1) min(-1)) or decile (>83 ml kg(-1) min(-1)) of maximal oxygen uptake. These data from the GEN-ATHLETE cohort do not support the hypothesis that the ACE ID polymorphism is associated with a higher cardiorespiratory endurance performance level.
引用
收藏
页码:1571 / 1575
页数:5
相关论文
共 44 条
[1]   ACE gene polymorphism: Ischemic heart disease and longevity in 10150 individuals - A case-referent and retrospective cohort study based on the Copenhagen City Heart Study [J].
AgerholmLarsen, B ;
Nordestgaard, BG ;
Steffensen, R ;
Sorensen, TIA ;
Jensen, G ;
TybjaergHansen, A .
CIRCULATION, 1997, 95 (10) :2358-2367
[2]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITION DOES NOT SUPPRESS PLASMA ANGIOTENSIN-II INCREASE DURING EXERCISE IN HUMANS [J].
ALDIGIER, JC ;
HUANG, H ;
DALMAY, F ;
LARTIGUE, M ;
BAUSSANT, T ;
CHASSAIN, AP ;
LEROUXROBERT, C ;
GALEN, FX .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (02) :289-295
[3]  
Bouchard C, 1996, PENN CTR N, V5, P470
[4]   Genomic scan for maximal oxygen uptake and its response to training in the HERITAGE Family Study [J].
Bouchard, C ;
Rankinen, T ;
Chagnon, YC ;
Rice, T ;
Pérusse, L ;
Gagnon, J ;
Borecki, I ;
An, P ;
Leon, AS ;
Skinner, JS ;
Wilmore, JH ;
Province, M ;
Rao, DC .
JOURNAL OF APPLIED PHYSIOLOGY, 2000, 88 (02) :551-559
[5]   Familial aggregation of VO2max response to exercise training:: results from the HERITAGE Family Study [J].
Bouchard, C ;
An, P ;
Rice, T ;
Skinner, JS ;
Wilmore, JH ;
Gagnon, J ;
Pérusse, L ;
Leon, AS ;
Rao, DC .
JOURNAL OF APPLIED PHYSIOLOGY, 1999, 87 (03) :1003-1008
[6]   Familial resemblance for VO2max in the sedentary state:: the HERITAGE Family Study [J].
Bouchard, C ;
Daw, EW ;
Rice, T ;
Pérusse, L ;
Gagnon, J ;
Province, MA ;
Leon, AS ;
Rao, DC ;
Skinner, JS ;
Wilmore, JH .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1998, 30 (02) :252-258
[7]  
Bouchard C, 1992, Exerc Sport Sci Rev, V20, P27
[8]  
BOUCHARD C, 1986, MED SCI SPORT EXER, V18, P639
[9]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[10]  
EVANS AE, 1994, Q J MED, V87, P211